Prelude Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $590K | Buy |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $237K | Buy |
|
|||||
|
2021
Q2 | $342K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $129K | Sell |
|
|||||
|
2020
Q2 | $364K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $351K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $298K | Sell |
|
|||||
|
2018
Q1 | $509K | Sell |
|
|||||
|
2017
Q4 | $589K | Buy |
|